BioRestorative Therapies (BRTX) Change in Acquisitions & Divestments (2023 - 2025)

BioRestorative Therapies (BRTX) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 40.07% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.7 million (down 45.64% YoY) and the FY2025 annual result came in at $11.7 million, down 45.64% from the prior year.
• Change in Acquisitions & Divestments declined to $2.5 million in Q4 2025, from $2.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.1 million in Q3 2023 to a low of $2.5 million in Q4 2025.
• A 3-year average of $4.5 million and a median of $4.1 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments surged 43.94% — and 2025, when it slumped 60.83%.
• Tracing BRTX's Change in Acquisitions & Divestments over 3 years: stood at $2.9 million in 2023, then soared by 43.94% to $4.1 million in 2024, then sank by 40.07% to $2.5 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $2.5 million (Q4 2025), $2.5 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.